Johanna Joyce, President of European Association for Cancer Research (EACR), shared European Association for Cancer Research (EACR)’s post on LinkedIn, adding:
“We at EACR are delighted to partner with ESMO for an important new initiative – joint educational sessions at the annual ESMO Congress – in the series ‘What oncologists should know about..’
At ESMO2026, we will be discussing RAS biology, DNA repair, cancer plasticity, tumor heterogeneity, tumor antigens and the tumor microenvironment.
Find out more about our sessions.
We are looking forward to meet you in Madrid!”
Quoting European Association for Cancer Research (EACR)’s post:
“At this year’s European Society for Medical Oncology Congress we’re collaborating on two EACR-ESMO educational sessions to give clinicians background knowledge on the molecular basis of cancer.
Make sure to add them to your calendar:
- Saturday, 24 October – What oncologists should know about molecular oncology (in collaboration with EACR)
- Sunday, 25 October – What oncologists should know about tumor microenvironment, antigens, and heterogeneity (in collaboration with EACR)
You can also read: OncoDaily at ESMO 2026: Where Science Meets Community
